Related Experiment Videos
[Antitachycardia pacing efficacy significantly improves with cardiac resynchronization therapy]
Ignacio Fernández Lozano1, Steven Higgins, Juan M Escudier Villa
1Servicio de Cardiología, Clínica Puerta de Hierro, Madrid, Spain. ifernandezl@sego.es
Revista Espanola De Cardiologia
|October 22, 2005
Summary
Cardiac resynchronization therapy significantly improves antitachycardia pacing success in heart failure patients. Biventricular pacing is more effective for treating tachycardia when combined with CRT.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Context:
- Heart failure is a complex condition often requiring advanced device therapy.
- Antitachycardia pacing (ATP) is a crucial feature of implantable cardioverter-defibrillators (ICDs) for managing tachyarrhythmias.
- The impact of cardiac resynchronization therapy (CRT) on ATP efficacy remained unclear.
Purpose:
- To determine the effect of CRT on the efficacy of ATP in heart failure patients with ICDs.
- To compare ATP success rates in patients with and without CRT.
Summary:
- A randomized trial involving 490 heart failure patients compared ATP efficacy with and without CRT.
- Patients receiving CRT demonstrated a significantly higher sinus rhythm conversion rate (90.5%) compared to the control group (69.1%).
- Biventricular ATP was found to be significantly more effective in CRT recipients.
Impact:
- CRT enhances the effectiveness of ATP in managing tachyarrhythmias in heart failure patients.
- These findings support the combined use of CRT and ATP for improved patient outcomes.
- Optimizing device therapy in heart failure can lead to better arrhythmia control.